Seres Therapeutics (1S90.F) Q2 2025 Earnings

7MayConfirmed
Q1 2025
Q2 2025
-3.62
-1.31
1
3.32

Details

Expected EPS
0.09021009676
Actual EPS
3.3156375000000002
Surprise EPS
3.23
Surprise Percent
+3,575.46%

Description

Seres Therapeutics (1S90.F) has reported earnings of 3.3156375000000002 per share for Q2 2025.

0 Comments

Share your thoughts